NIH-funded research R21 grant

How a tick protein affects skin inflammation and immune response

Official title: Subversion of Keratinocyte Function by a Tick Salivary Protein

Funded at University of Maryland Baltimore · NIH-11036329 · Data updated 2026-11-12

This study is looking at how a protein from tick saliva might help reduce skin inflammation when ticks bite, which could help us understand how tick bites affect skin health and diseases.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Maryland Baltimore
NIH-funded
Lab location1 site (Baltimore, United States)
Project startFebruary 16, 2024
Project endDecember 31, 2025
Funding year2025
Award (this year)$194,375
NIH project number5R21AI178839-02
Project IDNIH-11036329 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced tick bites or suffer from skin inflammation related to tick-borne diseases.

Less likely to help

Patients who do not have a history of tick exposure or related skin conditions may not benefit from this research.

What this research studies

This research investigates how a protein from tick saliva, known as sialostatin L2, interacts with a protein in human skin cells called HMGB1. When a tick feeds, it can trigger inflammation in the skin, but this tick protein may help suppress that inflammation, allowing the tick to feed more effectively. The study aims to understand the mechanisms behind this interaction and how it affects the immune response in skin cells, particularly keratinocytes, which are crucial for skin health. By exploring this relationship, the research could provide insights into how tick bites influence skin diseases and inflammation.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for skin inflammation and related conditions caused by tick bites.

How similar studies have gone: While the specific interaction being studied is novel, previous research has shown that tick saliva can influence immune responses, indicating potential for success in this area.

Where this research is happening

  • University of Maryland Baltimore
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Pedra, Joao — University of Maryland Baltimore
  • Study coordinator: Pedra, Joao

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.